Actively Recruiting
Effectiveness of PRP Pharmacopuncture for Chronic Neck Pain in Cervical Myofascial Syndrome of the Upper Trapezius
Led by Indonesia University · Updated on 2026-04-16
72
Participants Needed
1
Research Sites
47 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical trial is to learn whether pharmacopuncture with Platelet-Rich Plasma (PRP) is effective for treating chronic neck pain in cervical myofascial syndrome related to the upper trapezius muscle. The main questions it aims to answer are: 1. Is pharmacopuncture with Platelet-Rich Plasma (PRP) effective in reducing chronic neck pain in patients with cervical myofascial syndrome related to the upper trapezius muscle? 2. Does PRP pharmacopuncture improve functional outcomes and quality of life in these patients? 3. Are there any adverse effects associated with PRP pharmacopuncture in this context? Researchers will compare PRP pharmacopuncture to normal saline pharmacopuncture (placebo) to evaluate whether PRP provides greater effectiveness in reducing chronic neck pain in cervical myofascial syndrome related to the upper trapezius muscle. Participants will: * Receive a single session of pharmacopuncture therapy * Undergo evaluations at week 2, week 4, and week 8 after the intervention
CONDITIONS
Official Title
Effectiveness of PRP Pharmacopuncture for Chronic Neck Pain in Cervical Myofascial Syndrome of the Upper Trapezius
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female, aged 18 to 59 years.
- Neck pain lasting more than 3 months.
- Neck pain classified as Grade I to III by the Neck Pain Task Force.
- Referred pain pattern matching the upper trapezius muscle on physical exam.
- Pain score between 30 and 70 mm on the Visual Analogue Scale during activity.
- Willing to participate fully and sign informed consent.
You will not qualify if you...
- Hemoglobin less than 13 g/dL for males or less than 12 g/dL for females.
- Platelet count below 150,000 per microliter.
- Fever of 37.56C or higher.
- Diagnosis of fibromyalgia.
- Cervical spine structural abnormalities other than degenerative changes.
- History of cervical spine surgery.
- Tumors, wounds, or skin infections at needle sites.
- Blood disorders or use of anticoagulant or antiplatelet drugs.
- History of acupuncture hypersensitivity.
- Uncontrolled heart disease or diabetes.
- Pharmacopuncture therapy to upper trapezius in past 6 months.
- Use of anti-inflammatory drugs in past 2 weeks.
- Currently pregnant or breastfeeding.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Fakultas Kedokteran Universitas Indonesia
Jakarta, Indonesia
Actively Recruiting
Research Team
I
Irma Nareswari, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here